Subscribe to our Newsletters !!

    https://www.cdc.gov/fungal/diseases/mucormycosis/index.html#:~:text=Mucormycosis(previouslycalledzygomycosis)is

    Cadila Pharma launches Posaconazole for treatment of fungal diseases

    21 June 2021, Ahmedabad: Pharma major Cadila Pharmaceuticals has launched a new triazole antifungal drug Posaconazole, which has been found to be effective against a wide range of invasive fungal diseases. The drug has also been recommended as a second-line treatment for Mucormycosis or black fungus as it is commonly known. Posaconazole is approved for